High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway

International Journal of Molecular Medicine

Volumn 37, Issue 5, 2016, Pages 1189-1198

  Huang, Wufeng ^a   Zhao, Haijin ^a   Dong, Hangming ^a   Wu, Yue ^a   Yao, Lihong ^a   Zou, Fei ^a   Cai, Shaoxi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cell adhesion molecules; Epithelial cell biology; Epithelial injury; Inflammatory mediators in asthma; Lung epithelial permeability

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA CATENIN; CLAUDIN 1; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; OCCLUDIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UVOMORULIN; ION; MACROMOLECULE;

AIRWAY EPITHELIAL BARRIER; ARTICLE; CELL JUNCTION; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY FUNCTION; SIGNAL TRANSDUCTION; TRANSEPITHELIAL RESISTANCE; WESTERN BLOTTING; CELL LINE; MACROMOLECULE; METABOLISM; PATHOLOGY; PERMEABILITY; RESPIRATORY MUCOSA;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; CELL LINE; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HMGB1 PROTEIN; HUMANS; INTERCELLULAR JUNCTIONS; INTERLEUKIN-1BETA; IONS; MACROMOLECULAR SUBSTANCES; PERMEABILITY; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84963619571     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2537     Document Type: Article

References (38)

1. Holgate ST, Roberts G, Arshad HS, Howarth PH and Davies DE: The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc 6: 655-659, 2009.
2. Bazzoni G: Pathobiology of junctional adhesion molecules. Antioxid Redox Signal 15: 1221-1234, 2011.
3. Steed E, Balda MS and Matter K: Dynamics and functions of tight junctions. Trends Cell Biol 20: 142-149, 2010.
4. Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, Haitchi HM, Vernon-Wilson E, Sammut D, Bedke N, et al: Defective epithelial barrier function in asthma. J Allergy Clin Immunol 128: 549-556 e541-512, 2011.
5. Baum B and Georgiou M: Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 192: 907-917, 2011.
6. Gumbiner B and Simons K: A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J Cell Biol 102: 457-468, 1986.
7. Castiglioni A, Canti V, Rovere-Querini P and Manfredi AA: High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res 343: 189-199, 2011.
8. Straub C, Midoro-Horiuti T, Goldblum R, Pazdrak K and Kurosky A: Elucidating the role of high mobility group box 1 (HMGB1) cytokine in a murine model of allergic asthma. J Allergy Clin Immunol 125: AB108, 2010.
9. Kanazawa H, Tochino Y, Asai K, Ichimaru Y, Watanabe T and Hirata K: Validity of HMGB1 measurement in epithelial lining fuid in patients with COPD. Eur J Clin Invest 42: 419-426, 2012.
10. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, et al: Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstr uctive pulmonary disease. Am J Respir Crit Care Med 181: 917-927, 2010.
11. Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S and Zou F: High mobility group protein B1 (HMGB1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17: 807-815, 2011.
12. Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, Yamamoto Y, Schmidt AM, Armour CL, Hughes JM, et al: Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway infammation. J Allergy Clin Immunol 134: 440-450, 2014.
13. Milutinovic PS, Alcorn JF, Englert JM, Crum LT and Oury TD: The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol 181: 1215-1225, 2012.
14. Di Candia L, Saunders R and Brightling CE: The RAGE against the storm. Eur Respir J 39: 515-517, 2012.
15. Lee CC, Lai YT, Chang HT, Liao JW, Shyu WC, Li CY and Wang CN: Inhibition of high-mobility group box 1 in lung reduced airway infammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol 86: 940-949, 2013.
16. Shim EJ, Chun E, Lee HS, Bang BR, Kim TW, Cho SH, Min KU and Park HW: The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy 42: 958-965, 2012.
17. Mitroulis I, Skendros P and Ritis K: Targeting IL-1beta in disease; The expanding role of NLRP3 infammasome. Eur J Intern Med 21: 157-163, 2010.
18. Sha Y, Zmijewski J, Xu Z and Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180: 2531-2537, 2008.
19. Bianchi ME: HMGB1 loves company. J Leukoc Biol 86: 573-576, 2009.
20. Zhang D, Zhao H, Zhou L, Song J, Dong H, Zou F and Cai S: High-mobility group box protein 1 in synergy with interleukin-1β promotes interleukin-8 expression in human airway epithelial cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 32: 1764-1767, 2012 (In Chinese).
21. Wan H, Winton HL, Soeller C, Stewart GA, Thompson PJ, Gruenert DC, Cannell MB, Garrod DR and Robinson C: Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur Respir J 15: 1058-1068, 2000.
22. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL and Fink MP: HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123: 790-802, 2002.
23. Wolfson RK, Chiang ET and Garcia JG: HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc Res 81: 189-197, 2011.
24. Huang W, Liu Y, Li L, Zhang R, Liu W, Wu J, Mao E and Tang Y: HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways. Infammation 35: 350-362, 2012.
25. Hardyman MA, Wilkinson E, Martin E, Jayasekera N P, Blume C, Swindle EJ, Gozzard N, Holgate ST, Howarth PH, Davies DE and Collins JE: TNF-alpha-mediated bronchial barrier disruption and regulation by src-family kinase activation. J Allergy Clin Immunol 132: 665-675 e668, 2013.
26. Walsh SV, Hopkins AM and Nusrat A: Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41: 303-313, 2000.
27. Yanai H, Ban T and Taniguchi T: High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol 33: 633-640, 2012.
28. Heijink IH, Kies PM, Kauffman HF, Postma DS, van Oosterhout AJ and Vellenga E: Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. J Immunol 178: 7678-7685, 2007.
29. Heijink IH, van Oosterhout A and Kapus A: Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. Eur Respir J 36: 1016-1026, 2010.
30. Petecchia L, Sabatini F, Varesio L, Camoirano A, Usai C, Pezzolo A and Rossi GA: Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway. Chest 135: 1502-1512, 2009.
31. Song J, Zhao H, Dong H, Zhang D, Zou M, Tang H, Liu L, Liang Z, Lv Y, Zou F and Cai S: Mechanism of E-cadherin redistribution in bronchial airway epithelial cells in a TDI-induced asthma model. Toxicol Lett 220: 8-14, 2013.
32. 2-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol 279: C21-C30, 2000.
33. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005.
34. Nawijn MC, Hackett TL, Postma DS, van Oosterhout AJ and Heijink IH: E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol 32: 248-255, 2011.
35. Lambrecht BN and Hammad H: The airway epithelium in asthma. Nat Med 18: 684-692, 2012.
36. Pantano C, Ather JL, Alcorn JF, Poynter ME, Brown AL, Guala AS, Beuschel SL, Allen GB, Whittaker LA, Bevelander M, et al: Nuclear factor-kappaB activation in airway epithelium induces infammation and hyperresponsiveness. Am J Respir Crit Care Med 177: 959-969, 2008.
37. Wachtel M, Bolliger MF, Ishihara H, Frei K, Bluethmann H and Gloor SM: Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB activation. J Neurochem 78: 155-162, 2001.
38. West MR, Ferguson DJ, Hart VJ, Sanjar S and Man Y: Maintenance of the epithelial barrier in a bronchial epithelial cell line is dependent on functional E-cadherin local to the tight junctions. Cell Commun Adhes 9: 29-44, 2002.